Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transition to Paliperidone ER in Schizophrenia
NCT00757705Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Mar 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of paliperidone in schizophrenia, sponsored by Johnson & Johnson. Started Mar 2008; status: completed.
02
Drugs
paliperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00757705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00757705.